| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |